Article

You have full text access to this OnlineOpen article

Designed zinc finger protein interacting with the HIV-1 integrase recognition sequence at 2-LTR-circle junctions

  1. Supachai Sakkhachornphop1,2,
  2. Supat Jiranusornkul3,
  3. Kanchanok Kodchakorn4,
  4. Sawitree Nangola1,
  5. Thira Sirisanthana2,
  6. Chatchai Tayapiwatana1,5,*

Article first published online: 21 AUG 2009

DOI: 10.1002/pro.233

Issue

Protein Science

Protein Science

Volume 18, Issue 11, pages 2219–2230, November 2009

Additional Information

How to Cite

Sakkhachornphop, S., Jiranusornkul, S., Kodchakorn, K., Nangola, S., Sirisanthana, T. and Tayapiwatana, C. (2009), Designed zinc finger protein interacting with the HIV-1 integrase recognition sequence at 2-LTR-circle junctions. Protein Science, 18: 2219–2230. doi: 10.1002/pro.233

Author Information

  1. 1

    Division of Clinical Immunology, Department of Medical Technology, Faculty of Associated Medical Sciences, Chiang Mai University, Chiang Mai 50200, Thailand

  2. 2

    Research Institute for Health Sciences, Chiang Mai University, Chiang Mai 50200, Thailand

  3. 3

    Department of Pharmaceutical Sciences, Faculty of Pharmacy, Chiang Mai University, Chiang Mai 50200, Thailand

  4. 4

    Thailand Excellence Center for Tissue Engineering, Department of Biochemistry, Faculty of Medicine, Chiang Mai University, Chiang Mai 50200, Thailand

  5. 5

    Biomedical Technology Research Unit, National Center for Genetic Engineering and Biotechnology, National Science and Technology Development Agency at the Faculty of Associated Medical Sciences, Chiang Mai University, Chiang Mai 50200, Thailand

*Division of Clinical Immunology, Department of Medical Technology, Faculty of Associated Medical Sciences, Chiang Mai University, Chiang Mai 50200, Thailand

Publication History

  1. Issue published online: 23 OCT 2009
  2. Article first published online: 21 AUG 2009
  3. Accepted manuscript online: 21 AUG 2009 12:00AM EST
  4. Manuscript Accepted: 13 AUG 2009
  5. Manuscript Received: 27 JUN 2009

Funded by

  • Royal Golden Jubilee Ph.D Program. Grant Number: PHD/0112/2550
  • The Fogarty AIDS International for Research and Training Program
  • Johns Hopkins University, and the National Center for Genetic Engineering and Biotechnology (BIOTEC) of the National Science and Technology Development Agency, Thailand

SEARCH

SEARCH BY CITATION

ARTICLE TOOLS

View Full Article (HTML) Get PDF (910K)

References

  • 1
    Mann JM, Chin J, Piot P, Quinn T ( 1988) The international epidemiology of AIDS. Sci Am 259: 82–89.
  • 2
    UNAIDS/World Health Organization (2008) Report on the Global HIV/AIDS Epidemic. August, Mexico City.
  • 3
    Englund G, Theodore TS, Freed EO, Engelman A, Martin MA ( 1995) Integration is required for productive infection of monocyte-derived macrophages by human immunodeficiency virus type 1. J Virol 69: 3216–3219.
  • 4
    Engelman A, Englund G, Orenstein JM, Martin MA, Craigie R ( 1995) Multiple effects of mutations in human immunodeficiency virus type 1 integrase on viral replication. J Virol 69: 2729–2736.
  • 5
    Sakai H, Kawamura M, Sakuragi J, Sakuragi S, Shibata R, Ishimoto A, Ono N, Ueda S, Adachi A ( 1993) Integration is essential for efficient gene expression of human immunodeficiency virus type 1. J Virol 67: 1169–1174.
  • 6
    Swanstrom R, Delorbe WJ, Bishop JM, Varmus HE ( 1981) Nucleotide sequence of cloned unintegrated avian sarcoma virus DNA: viral DNA contains direct and inverted repeats similar to those in transposable elements. Proc Natl Acad Sci USA 78: 124–128.
  • 7
    Shoemaker C, Goff S, Gilboa E, Paskind M, Mitra SW, Baltimore D ( 1980) Structure of a cloned circular Moloney murine leukemia virus DNA molecule containing an inverted segment: implications for retrovirus integration. Proc Natl Acad Sci USA 77: 3932–3936.
  • 8
    Shank PR, Varmus HE ( 1978) Virus-specific DNA in the cytoplasm of avian sarcoma virus-infected cells is a precursor to covalently closed circular viral DNA in the nucleus. J Virol 25: 104–114.
  • 9
    Yoshimura FK, Weinberg RA ( 1979) Restriction endonuclease cleavage of linear and closed circular murine leukemia viral DNAs: discovery of a smaller circular form. Cell 16: 323–332.
  • 10
    Fritsch E, Temin HM ( 1977) Formation and structure of infectious DNA of spleen necrosis virus. J Virol 21: 119–130.
  • 11
    Guntaka RV, Richards OC, Shank PR, Kung HJ, Davidson N ( 1976) Covalently closed circular DNA of avian sarcoma virus: purification from nuclei of infected quail tumor cells and measurement by electron microscopy and gel electrophoresis. J Mol Biol 106: 337–357.
  • 12
    Gianni AM, Smotkin D, Weinberg RA ( 1975) Murine leukemia virus: detection of unintegrated double-stranded DNA forms of the provirus. Proc Natl Acad Sci USA 72: 447–451.
  • 13
    Vink C, Plasterk RH ( 1993) The human immunodeficiency virus integrase protein. Trends Genet 9: 433–438.
  • 14
    Katz RA, Skalka AM ( 1994) The retroviral enzymes. Annu Rev Biochem 63: 133–173.
  • 15
    De Clercq E ( 2001) New developments in anti-HIV chemotherapy. Curr Med Chem 8: 1543–1572.
  • 16
    Evering TH, Markowitz M ( 2008) Raltegravir: an integrase inhibitor for HIV-1. Expert Opin Invest Drugs 17: 413–422.
  • 17
    Grant P, Zolopa A ( 2008) Integrase inhibitors: a clinical review of raltegravir and elvitegravir. J HIV Ther 13: 36–39.
  • 18
    Delelis O, Malet I, Na L, Tchertanov L, Calvez V, Marcelin AG, Subra F, Deprez E, Mouscadet JF ( 2009) The G140S mutation in HIV integrases from raltegravir-resistant patients rescues catalytic defect due to the resistance Q148H mutation. Nucleic Acids Res 37: 1193–1201.
  • 19
    Hicks C, Gulick RM, Roquebert B, Blum L, Collin G, Damond F, Peytavin G, Leleu J, Matheron S, Chene G, Brun-Vezinet F, Descamps D ( 2009) Raltegravir: the first HIV type 1 integrase inhibitor selection of the Q148R integrase inhibitor resistance mutation in a failing raltegravir containing regimen. Clin Infect Dis 48: 931–939.
  • 20
    Charpentier C, Karmochkine M, Laureillard D, Tisserand P, Belec L, Weiss L, Si-Mohamed A, Piketty C ( 2008) Drug resistance profiles for the HIV integrase gene in patients failing raltegravir salvage therapy. HIV Med 9: 765–770.
  • 21
    Miller J, Mclachlan AD, Klug A ( 1985) Repetitive zinc-binding domains in the protein transcription factor IIIA from Xenopus oocytes. EMBO J 4: 1609–1614.
  • 22
    Lee MS, Gippert GP, Soman KV, Case DA, Wright PE ( 1989) Three-dimensional solution structure of a single zinc finger DNA-binding domain. Science 245: 635–637.
  • 23
    Elrod-Erickson M, Rould MA, Nekludova L, Pabo CO ( 1996) Zif268 protein-DNA complex refined at 1.6 A°: a model system for understanding zinc finger-DNA interactions. Structure 4: 1171–1180.
  • 24
    Pavletich NP, Pabo CO ( 1991) Zinc finger-DNA recognition: crystal structure of a Zif268-DNA complex at 2.1 A°. Science 252: 809–817.
  • 25
    Zimmerman KA, Fischer KP, Joyce MA, Tyrrell DL ( 2008) Zinc finger proteins designed to specifically target duck hepatitis B virus covalently closed circular DNA inhibit viral transcription in tissue culture. J Virol 82: 8013–8021.
  • 26
    Dreier B, Segal DJ, Barbas CF ( 2000) Insights into the molecular recognition of the 5′-GNN-3′ family of DNA sequences by zinc finger domains. J Mol Biol 303: 489–502.
  • 27
    Dreier B, Fuller RP, Segal DJ, Lund CV, Blancafort P, Huber A, Koksch B, Barbas CF ( 2005) Development of zinc finger domains for recognition of the 5′-CNN-3′ family DNA sequences and their use in the construction of artificial transcription factors. J Biol Chem 280: 35588–35597.
  • 28
    Dreier B, Beerli RR, Segal DJ, Flippin JD, Barbas CF ( 2001) Development of zinc finger domains for recognition of the 5′-ANN-3′ family of DNA sequences and their use in the construction of artificial transcription factors. J Biol Chem 276: 29466–29478.
  • 29
    Blancafort P, Segal DJ, Barbas CF ( 2004) Designing transcription factor architectures for drug discovery. Mol Pharmacol 66: 1361–1371.
  • 30
    Mandell JG, Barbas CF ( 2006) Zinc finger tools: custom DNA-binding domains for transcription factors and nucleases. Nucleic Acids Res 34: W516–W523.
  • 31
    Altschul SF, Madden TL, Schäffer AA, Zhang J, Zhang Z, Miller W, Lipman DJ ( 1997) Gapped BLAST and PSI-BLAST: a new generation of protein database search programs. Nucleic Acids Res 25: 3389–3402.
  • 32
    Deprez E, Barbe S, Kolaski M, Leh H, Zouhiri F, Auclair C, Brochon JC, Le Bret M, Mouscadet JF ( 2004) Mechanism of HIV-1 integrase inhibition by styrylquinoline derivatives in vitro. Mol Pharmacol 65: 85–98.
  • 33
    Bugreev DV, Baranova S, Zakharova OD, Parissi V, Desjobert C, Sottofattori E, Balbi A, Litvak S, Tarrago-Litvak L, Nevinsky GA ( 2003) Dynamic, thermodynamic, and kinetic basis for recognition and transformation of DNA by human immunodeficiency virus type 1 integrase. Biochemistry 42: 9235–9247.
  • 34
    Segal DJ, Crotty JW, Bhakta MS, Barbas CF, Horton NC, Mandell JG, Eberhardy SR, Goncalves J, Coelho S, Berkhout B, Dreier B, Fuller R, Lund CV, Blancafort P, Huber A, Koksch B ( 2006) Structure of Aart, a designed six-finger zinc finger peptide, bound to DNA. J Mol Biol 363: 405–421.
  • 35
    Balakrishnan M, Jonsson CB ( 1997) Functional identification of nucleotides conferring substrate specificity to retroviral integrase reactions. J Virol 71: 1025–1035.
  • 36
    Katzman M, Sudol M ( 1996) Influence of subterminal viral DNA nucleotides on differential susceptibility to cleavage by human immunodeficiency virus type 1 and visna virus integrases. J Virol 70: 9069–9073.
  • 37
    Yoshinaga T, Fujiwara T ( 1995) Different roles of bases within the integration signal sequence of human immunodeficiency virus type 1 in vitro. J Virol 69: 3233–3236.
  • 38
    Van den Ent FM, Vink C, Plasterk RH ( 1994) DNA substrate requirements for different activities of the human immunodeficiency virus type 1 integrase protein. J Virol 68: 7825–7832.
  • 39
    Vink C, Van Gent DC, Elgersma Y, Plasterk RH ( 1991) Human immunodeficiency virus integrase protein requires a subterminal position of its viral DNA recognition sequence for efficient cleavage. J Virol 65: 4636–4644.
  • 40
    Lafemina RL, Callahan PL, Cordingley MG ( 1991) Substrate specificity of recombinant human immunodeficiency virus integrase protein. J Virol 65: 5624–5630.
  • 41
    Reynolds L, Ullman C, Moore M, Isalan M, West MJ, Clapham P, Klug A, Choo Y ( 2003) Repression of the HIV-1 5′ LTR promoter and inhibition of HIV-1 replication by using engineered zinc-finger transcription factors. Proc Natl Acad Sci USA 100: 1615–1620.
  • 42
    Segal DJ, Goncalves J, Eberhardy S, Swan CH, Torbett BE, Li X, Barbas CF ( 2004) Attenuation of HIV-1 replication in primary human cells with a designed zinc finger transcription factor. J Biol Chem 279: 14509–14519.
  • 43
    Rebar EJ, Huang Y, Hickey R, Nath AK, Meoli D, Nath S, Chen B, Xu L, Liang Y, Jamieson AC, Zhang L, Spratt SK, Case CC, Wolffe A, Giordano FJ ( 2002) Induction of angiogenesis in a mouse model using engineered transcription factors. Nat Med 8: 1427–1432.
  • 44
    Lanao JM, Briones E, Colino CI ( 2007) Recent advances in delivery systems for anti-HIV1 therapy. J Drug Target 15: 21–36.
  • 45
    Whitcomb JM, Kumar R, Hughes SH ( 1990) Sequence of the circle junction of human immunodeficiency virus type 1: implications for reverse transcription and integration. J Virol 64: 4903–4906.
  • 46
    Grote A, Hiller K, Scheer M, Munch R, Nortemann B, Hempel DC, Jahn D ( 2005) JCat: a novel tool to adapt codon usage of a target gene to its potential expression host. Nucleic Acids Res 33: W526–W531.
  • 47
    Wilkins MR, Gasteiger E, Bairoch A, Sanchez JC, Williams KL, Appel RD, Hochstrasser DF ( 1999) Protein identification and analysis tools in the ExPASy server. Methods Mol Biol 112: 531–552.
  • 48
    Nair R, Rost B ( 2005) Mimicking cellular sorting improves prediction of subcellular localization. J Mol Biol 348: 85–100.
  • 49
    Stote RH, Karplus M ( 1995) Zinc binding in proteins and solution: a simple but accurate nonbonded representation. Proteins 23: 12–31.
  • 50
    Duan Y, Wu C, Chowdhury S, Lee MC, Xiong G, Zhang W, Yang R, Cieplak P, Luo R, Lee T, Caldwell J, Wang J, Kollman P ( 2003) A point-charge force field for molecular mechanics simulations of proteins based on condensed-phase quantum mechanical calculations. J Comput Chem 24: 1999–2012.
  • 51
    Jorgensen WL, Chandrasekhar J, Madura JD, Impey RW, Klein ML ( 1983) Comparison of simple potential functions for simulating liquid water. J Chem Phys 79: 926–935.
  • 52
    Jiranusornkul S, Laughton CA ( 2008) Destabilization of DNA duplexes by oxidative damage at guanine: implications for lesion recognition and repair. J R Soc Interface 5 (Suppl 3): S191–S198.
  • 53
    Onufriev A, Bashford D, Case DA ( 2000) Modification of the generalized Born model suitable for macromolecules. J Phys Chem B 104: 3712–3720.
View Full Article (HTML) Get PDF (910K)